Bloomberg Television published this video item, entitled “Obesity Drugs: When Can Patients Stop Taking Them?” – below is their description.
Two years and more than a million prescriptions after Wegovy first went on sale, there’s one taboo question for some doctors who prescribe Novo Nordisk A/S’s hit obesity drug: When can patients stop taking it? Bloomberg’s Naomi Kresge explains.
——–
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com
Connect with us on…
Twitter: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness
Instagram: https://www.instagram.com/bloombergbusiness/
Bloomberg Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.